Damora Therapeutics (DMRA) Change in Acquisitions & Divestments (2021 - 2024)

Damora Therapeutics' Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $6.0 million for Q2 2024.

• Quarterly Change in Acquisitions & Divestments fell 51.35% year-over-year to $6.0 million in Q2 2024, while the trailing twelve-month figure through Dec 2024 was $11.6 million (down 75.82% YoY) and the FY2024 annual result came in at $11.6 million, down 75.82% from the prior year.
• Change in Acquisitions & Divestments was $6.0 million for Q2 2024 at Damora Therapeutics, up from $5.6 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $18.6 million in Q4 2022 and bottomed at $5.6 million in Q1 2024.
• A 4-year average of $11.8 million and a median of $12.3 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments jumped 44.71% — and 2024, when it plunged 60.0%.
• Damora Therapeutics' Change in Acquisitions & Divestments stood at $14.4 million in 2021, then gained by 28.96% to $18.6 million in 2022, then slumped by 48.89% to $9.5 million in 2023, then slumped by 36.82% to $6.0 million in 2024.
• Business Quant data shows DMRA's Change in Acquisitions & Divestments at $6.0 million in Q2 2024, $5.6 million in Q1 2024, and $9.5 million in Q4 2023.